Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study

BACKGROUND AND OBJECTIVES: Oral sodium zirconium cyclosilicate (formerly ZS-9) binds and removes potassium via the gastrointestinal tract. Sodium zirconium cyclosilicate–associated restoration and maintenance of normokalemia and adverse events were evaluated in a two-part, open label, phase 3 trial....

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Clin J Am Soc Nephrol
Huvudupphovsmän: Spinowitz, Bruce S., Fishbane, Steven, Pergola, Pablo E., Roger, Simon D., Lerma, Edgar V., Butler, Javed, von Haehling, Stephan, Adler, Scott H., Zhao, June, Singh, Bhupinder, Lavin, Philip T., McCullough, Peter A., Kosiborod, Mikhail, Packham, David K.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society of Nephrology 2019
Ämnen:
Original Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6556727/
https://ncbi.nlm.nih.gov/pubmed/31110051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.12651018
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk